MBI 226 Acne Solutions

DRUG2 trials

Sponsors

BioWest Therapeutics Inc

Conditions

AcneAcne VulgarisPropionibacterium Acnes

Phase 2

Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne

CompletedNCT00211497

BioWest Therapeutics IncAcne, Acne Vulgaris, Propionibacterium Acnes

Start: 2003-01-31End: 2003-09-30Target: 255Updated: 2005-09-21

Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne

CompletedNCT00211523

BioWest Therapeutics IncAcne, Acne Vulgaris, Propionibacterium Acnes

Start: 2000-10-31End: 2001-09-30Target: 75Updated: 2005-09-21